AFA
CL icon

Abacus FCF Advisors’s Colgate-Palmolive CL Stock Holding History

Abacus FCF Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.3M Sell
132,905
-95,580
-42% -$8.52M 2.55% 12
2025
Q4 		$18.1M Buy
228,485
+5,310
+2% +$416K 2.36% 9
2025
Q3 		$17.8M Buy
223,175
+22,105
+11% +$1.89M 2.37% 12
2025
Q2 		$18.3M Buy
201,070
+38,907
+24% +$3.55M 2.56% 11
2025
Q1 		$15.2M Buy
162,163
+64,742
+66% +$5.8M 2.39% 12
2024
Q4 		$8.86M Buy
97,421
+39,530
+68% +$3.77M 1.17% 16
2024
Q3 		$6.01M Sell
57,891
-2,170
-4% -$221K 1.39% 17
2024
Q2 		$5.83M Sell
60,061
-2,478
-4% -$229K 1.45% 10
2024
Q1 		$5.63M Buy
62,539
+20,758
+50% +$1.76M 1.41% 16
2023
Q4 		$3.33M Buy
41,781
+19,381
+87% +$1.46M 0.97% 26
2023
Q3 		$1.59M Sell
22,400
-606
-3% -$45.3K 0.85% 30
2023
Q2 		$1.77M Buy
23,006
+2,531
+12% +$196K 0.89% 35
2023
Q1 		$1.54M Buy
20,475
+2,660
+15% +$198K 0.82% 38
2022
Q4 		$1.4M Buy
17,815
+3,372
+23% +$253K 0.92% 26
2022
Q3 		$1.01M Sell
14,443
-1,060
-7% -$83.1K 0.7% 46
2022
Q2 		$1.24M Sell
15,503
-8,556
-36% -$669K 0.76% 46
2022
Q1 		$1.82M Buy
24,059
+10,056
+72% +$797K 0.61% 53
2021
Q4 		$1.2M Hold
14,003
– – 0.59% 82
2021
Q3 		$1.07M Sell
14,003
-8,872
-39% -$704K 0.52% 99
2021
Q2 		$1.86M Sell
22,875
-1,694
-7% -$139K 0.95% 26
2021
Q1 		$1.95M Buy
24,569
+4,811
+24% +$377K 0.99% 29
2020
Q4 		$1.68M Sell
19,758
-1,845
-9% -$153K 0.98% 66
2020
Q3 		$1.72M Buy
21,603
+7,749
+56% +$591K 0.93% 70
2020
Q2 		$1.01M Sell
13,854
-615
-4% -$43.7K 0.96% 66
2020
Q1 		$944K Sell
14,469
-1,476
-9% -$104K 1.08% 55
2019
Q4 		$1.1M Sell
15,945
-369
-2% -$25.2K 0.87% 90
2019
Q3 		$1.2M Buy
16,314
+38
+0.2% +$2.76K 0.99% 68
2019
Q2 		$1.17M Buy
+16,276
New +$1.16M 0.96% 72

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Abacus FCF Advisors's CL Position: Q1 2026 in Review

Abacus FCF Advisors reduced its Colgate-Palmolive (CL) stake by 42% in Q1 2026, selling an estimated $8.52M and leaving 132,905 shares worth $11.3M. The position accounts for 2.55% of the portfolio, ranked #12.

Abacus FCF Advisors first reported a position in CL in Q2 2019 and has held it in 28 quarters since. The position peaked at $18.3M in Q2 2025. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Abacus FCF Advisors held 132,905 shares of Colgate-Palmolive worth $11.3M as of Q1 2026.
  • Abacus FCF Advisors sold 95,580 Colgate-Palmolive shares in Q1 2026, an estimated $8.52M.
  • Colgate-Palmolive made up 2.55% of Abacus FCF Advisors's portfolio in Q1 2026, its #12 holding.
  • Abacus FCF Advisors first reported a position in Colgate-Palmolive in Q2 2019 and has held it in 28 quarters since.
  • Abacus FCF Advisors's Colgate-Palmolive position peaked at $18.3M in Q2 2025.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Abacus FCF Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.